Julie Gralow
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Daily pill can double survival time for deadliest cancer, trial shows
A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest breakthroughs in decades. Currently, there are few treatments for pancreatic cancer, and most do little or nothing to help. For decades, scientists have worked relentlessly trying to find clever solutions for a form of cancer that is often found late.
'Holy grail' blood test to help NHS diagnose different cancers fails in trial
'Holy grail' blood test to help NHS diagnose different cancers fails in trial NHS hopes dashed after trial of the first multi-cancer blood test it had hoped would revolutionise treatment - but scientists say all may not be lost Hopes that a “revolutionary” cancer blood test could soon be rolled out on the NHS have been dashed after a trial failed to achieve its main goal. The NHS had hoped to prove that the first multi-cancer blood test, which has been dubbed the “Holy Grail” for medical...
Cancer breakthrough as new 'game-changing' pill could DOUBLE survival time for most deadly diseases
Cancer breakthrough as new 'game-changing' pill could DOUBLE survival time for most deadly diseases Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that A “game-changing” daily pill helped almost double survival time for patients with the most deadly major cancer. Pancreatic cancer patients on the drug lived for twice as long as those on chemotherapy. The pill’s success is thought to be the...